My watch list
my.chemeurope.com  
Login  

ThioTEPA



ThioTEPA
Systematic (IUPAC) name
N,N ' N '-triethylenethiophosphoramide
Identifiers
CAS number 52-24-4
ATC code L01AC01
PubChem 5453
Chemical data
Formula C6H12N3PS 
Mol. mass 189.219 g/mol
Pharmacokinetic data
Bioavailability  ?
Metabolism Hepatic (CYP2B6, CYP2C11)
Half life 2.4 hours
15-18 hours (metabolites)
Excretion Renal
Therapeutic considerations
Pregnancy cat.

D(AU) D(US)

Legal status

POM(UK) -only(US)

Routes IV, intracavitary, intravesical

N,N'N'-triethylenethiophosphoramide (ThioTEPA) is a cancer chemotherapeutic member of the alkylating agent group, now in use for over 50 years. It is a stable derivative of N,N',N''- triethylenephosphoramide (TEPA). It is mostly used to treat breast cancer, ovarian cancer and bladder cancer. It is also used as conditioning for Bone marrow transplantation. Its main toxicity is myelosuppression.

References

  • Sykes M et al. (1953). "Clinical Studies of triethylenephosphoramide compounds with nitrogen mustard-like activity". Cancer 6: 142-48.
  • Maanen MJ, Smeets CJ, Beijnen JH (2000). "Chemistry, pharmacology and pharmacokinetics of N,N',N" -triethylenethiophosphoramide (ThioTEPA)". Cancer Treat Rev 26 (4): 257-68. PMID 10913381.
 
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "ThioTEPA". A list of authors is available in Wikipedia.
Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE